Why Aren't More Doctors Prescribing Paxlovid to High-Risk Patients?

(MedPage Today) -- Recent evidence is piling up that many people at high risk for severe COVID-19 don't receive nirmatrelvir/ritonavir (Paxlovid) -- or any outpatient antiviral treatment -- when diagnosed with a SARS-CoV-2 infection. MedPage...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news